Thursday, November 19, 2015 6:39:24 PM
LECTURE
•Plasmid IL-12 Electroporation in Melanoma
•
Provider Statement: This continuing medical education activity is provided by Vindico Medical Education.
Support Statement: This activity is supported by an educational grant from Merck and Co., Inc.
Target Audience: The intended audience for the activities is medical oncologists, surgical oncologists, dermatologists, oncology nurses, nurse practitioners, physician assistants and other healthcare professionals involved in the treatment of patients with melanoma.
Learning Objectives: Upon successful completion of this educational activity, participants should be better able to assess the value of plasmid IL-12 electroporation in treating patients with advanced melanoma.
Faculty:
Alain Algazi, MD
Assistant Professor
UCSF Melanoma Oncology
UCSF Helen Diller Family
Comprehensive Cancer Center
San Francisco, California
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM